Related Content
- AlertMarch 24, 2022
Draft Implementing Rules of China’s Human Genetic Resources Regulations as Applied to Foreign Persons
- Goodwin InsightsMay 7, 2020
Chinese Cross Border Life Sciences Strategic Transactions in the Age of COVID-19
- AlertMarch 24, 2020
Hong Kong to Revamp Limited Partnership Regime to Attract Private Funds
- VideoMarch 13, 2019
Hong Kong Celebrates Ten Years
- VideoApril 5, 2018
Video: Goodwin in Asia
- VideoOctober 8, 2015
VIDEO: Goodwin’s Approach to Delivering the Best Value from Alternative Fee Arrangements
- AlertFebruary 3, 2014
Release of Names With Interests in Offshore Entities: Ramifications
- Press ReleaseJune 30, 2022
Palleon Pharmaceuticals and Henlius Enter into Strategic Collaboration to Develop Bifunctional Sialidase Therapies
- Press ReleaseMay 19, 2022
China’s Kelun Pharma Jumps on Licensing New Cancer Drug to Merck
- Press ReleaseJanuary 31, 2022
Goodwin Advises Trinity Acquisition on its Hong Kong SPAC Listing Application
- Press ReleaseJanuary 28, 2022
Goodwin Advises ELEVATE Management on ELEVATE Combination with LRQA
- Press ReleaseJanuary 20, 2022
Eluminex Biosciences Acquires Zuretinol Acetate Assets from Retinagenix Holdings
- Press ReleaseNovember 8, 2021
FountainVest Partners To Acquire Langdi Pharmaceutical
- Press ReleaseSeptember 17, 2021
Grifols To Acquire Tiancheng Pharmaceutical Holding, Largest Shareholder of Biotest, for EUR1.1 Billion
- Press ReleaseAugust 10, 2021
CardioFocus Announces Agreement with China Grand Pharmaceutical to Bring HeartLight X3 System to China